tiprankstipranks
Blurbs

Analysts Offer Insights on Healthcare Companies: Pediatrix Medical Group (MD), Apogee Therapeutics, Inc. (APGE) and Resmed (RMD)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Pediatrix Medical Group (MDResearch Report), Apogee Therapeutics, Inc. (APGEResearch Report) and Resmed (RMDResearch Report).

Pediatrix Medical Group (MD)

In a report issued on August 3, Ann Hynes from Mizuho Securities maintained a Hold rating on Pediatrix Medical Group, with a price target of $15.00. The company’s shares closed last Monday at $14.85.

According to TipRanks.com, Hynes is a 5-star analyst with an average return of 8.5% and a 60.3% success rate. Hynes covers the Healthcare sector, focusing on stocks such as Walgreens Boots Alliance, Molina Healthcare, and AmerisourceBergen.

The word on The Street in general, suggests a Hold analyst consensus rating for Pediatrix Medical Group with a $15.00 average price target, which is a 2.2% upside from current levels. In a report issued on August 4, Truist Financial also maintained a Hold rating on the stock with a price target.

See today’s best-performing stocks on TipRanks >>

Apogee Therapeutics, Inc. (APGE)

Guggenheim analyst Seamus Fernandez initiated coverage with a Buy rating on Apogee Therapeutics, Inc. today and set a price target of $29.00. The company’s shares closed last Monday at $20.50.

According to TipRanks.com, Fernandez is a 5-star analyst with an average return of 12.3% and a 57.9% success rate. Fernandez covers the Healthcare sector, focusing on stocks such as Arcutis Biotherapeutics, Arcturus Therapeutics, and Merck & Company.

Currently, the analyst consensus on Apogee Therapeutics, Inc. is a Moderate Buy with an average price target of $31.50, which is a 52.3% upside from current levels. In a report released today, Stifel Nicolaus also initiated coverage with a Buy rating on the stock with a $34.00 price target.

Resmed (RMD)

Mizuho Securities analyst Anthony Petrone maintained a Buy rating on Resmed on August 4 and set a price target of $255.00. The company’s shares closed last Monday at $186.67, close to its 52-week low of $178.16.

According to TipRanks.com, Petrone is a 4-star analyst with an average return of 4.8% and a 50.6% success rate. Petrone covers the Healthcare sector, focusing on stocks such as Axonics Modulation Technologies, GE Healthcare Technologies Inc, and Inspire Medical Systems.

Resmed has an analyst consensus of Strong Buy, with a price target consensus of $267.80, a 40.8% upside from current levels. In a report issued on August 1, RBC Capital also upgraded the stock to Buy with a $284.00 price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on MD:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles